𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evolutionary archeology: Current status and future prospects

✍ Scribed by Michael J. O'Brien; R. Lee Lyman


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
209 KB
Volume
11
Category
Article
ISSN
1060-1538

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Darwinian evolution can be defined minimally as β€œany net directional change or any cumulative change in the characteristics of … populations over many generationsβ€”in other words, descent with modification”^1^ (p. 5). In archeology the population comprises artifacts, which are conceived of as phenotypic.^2–4^ Extension of the human phenotype to include ceramic vessels, projectile points, and the like is based on the notion that artifacts are material expressions of behavior, which itself is phenotypic. Archeology's unique claim within the natural sciences is its access to past phenotypic characters. Thus, historical questions are the most obvious ones archeologists can ask, although admittedly this is hardly a strong warrant for asking them. But if the issue is evolution, then historical questions must be asked. Posing and answering historical questions is the goal of evolutionary archeology.^5^.


πŸ“œ SIMILAR VOLUMES


Organ transplantation in mice: Current s
✍ Robert Zhong πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 52 KB πŸ‘ 2 views

With the development of microsurgery and molecular biology in the 1990s, the mouse model for organ transplants has become increasingly popular. In the past 10 years, the number of studies using the mouse model has increased threefold. All the organ transplants, originally done in the rat model, can

Dopaminergic transplantation for parkins
✍ C. Warren Olanow; Jeffrey H. Kordower; Anthony E. Lang; Jose A. Obeso πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 258 KB πŸ‘ 2 views

## Abstract Cell‐based therapies that involve transplantation into the striatum of dopaminergic cells have attracted considerable interest as possible treatments for Parkinson's disease (PD). However, all double‐blind, sham‐controlled, studies have failed to meet their primary endpoints, and transp